Nisa Investment Advisors, LLC Aldeyra Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,581 shares of ALDX stock, worth $8,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,581
Previous 1,493
5.89%
Holding current value
$8,078
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ALDX
# of Institutions
127Shares Held
37.6MCall Options Held
757KPut Options Held
539K-
Perceptive Advisors LLC New York, NY9.28MShares$47.4 Million1.54% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$28 Million17.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$19.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.5 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.47MShares$7.5 Million0.17% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $298M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...